Table 1.
Demographic and clinical characteristics of HAV-infected pediatric patients and controls.
| Characteristic | Healthy controls (n = 60) |
Patients |
P value |
|
|---|---|---|---|---|
| HAV+ CB: >0.3–2 mg/dL (n = 70) |
HAV+ CB: >2 mg/dL (n = 86) |
|||
| Gender (% female) | 41 | 58 | 56 | NS |
| Mean age (years ± SD) | 6.5 ± 2.5 | 6.5 ± 3.425 | 8.05 ± 3.85 | NS |
| Mean ALT (IU/L ± SD) | 21.58 ± 13.72 | 733.39 ± 629.50 | 1471.06 ± 1238.43 | NS |
| Mean AST (IU/L ± SD) | 13.87 ± 9.99 | 513.94 ± 493.8 | 1041.06 ± 935.33 | <0.05 |
| Mean CB (mg/dL ± SD) | 0.20 ± 0.087 | 1.15 ± 0.70 | 5.33 ± 2.65 | — |
| Anti-HAV IgM | − | + | + | — |
| Anti-HAV IgG | − | − | − | — |
ALT: alanine aminotransferase; AST: aspartate aminotransferase; SD: standard deviation; NS: not significant.